A collaborative effort across 14 clinical centers in Canada and Australia reports that pregnant women with type 1 diabetes ...
Sprouts employs approximately 35,000 associates and operates more than 450 stores in 24 states nationwide. The Phoenix-based ...
In the absence of much federal action, states have enacted dozens of laws this year to lower prescription drug costs for ...
Is diabetes reversible? Here, endocrinologists explain the answer, including which types of diabetes can go into "remission" ...
(n){if(!window.cnxel){window.cnxel={},window.cnxel.cmd=[];var t=n.createElement('iframe');t.src='javascript:false'; t.display='none',t.onload=function(){var ...
A Texas woman who said she killed a former fiancé in self-defense has been convicted of murdering her fifth husband in 2023 — and now, prosecutors have reopened the investigation into the 2018 killing ...
Type 1 diabetes is an autoimmune disease (typically arising in younger people) that occurs when your immune system attacks ...
People looking to lose weight and lower their blood sugar may someday be able to get a single injection that turns their ...
Vertex has enacted or continued several key launches in 2025. These include its new once-daily triple-combination therapy for ...
The FDA has accepted for review the sBLA for Afrezza (insulin human) inhalation powder in children and adolescents with type 1 or 2 diabetes.
Medical device maker Dexcom topped Wall Street estimates for third-quarter results on Thursday, driven by robust demand for its continuous glucose monitoring systems.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results